Searched for
SUN PHARMA KIDNEY
India pharma companies develop versions of Wegovy to get in on weight-loss windfallIndian drugmakers are developing their versions of Novo Nordisk's weight-loss treatment, Wegovy, aiming to capitalize on the growing weight...
Sun Pharma scouting for innovative therapies to boost India businessApproved by the Indian drug regulator in May 2023, sovateltide can be administered within 24 hours for the treatment of ischemic stroke, al...
Healthtech platform Neodocs raises $2 million from Omidyar Network, othersWith this funding, Mumbai-based Neodocs aims to double down its investments in existing products, particularly focusing on its kidney care ...
Sun Pharma inks pact with Bayer to sell drug for chronic kidney diseaseSun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights...
Zydus bets big on proprietary drugs to boost revenueSharvil Patel, managing director of Zydus Lifesciences said, half of the research and development (R&D) allocation is geared towards develo...
Sun Pharma to market Zydus' novel anti-CKD drug desidustat in India“The addition of RYTSTAT further strengthens our nephrology portfolio in India," said Kirti Ganorkar, CEO - India Business, Sun Pharma.
AstraZeneca working on vaccine to prevent and cure Covid: MD Gagandeep SinghAnglo-Swedish pharma company AstraZeneca has mobilised research efforts to advance the development of a novel coronavirus-neutralising long...
Local firms got voluntary license for more drugs during pandemicA voluntary licence (VL) is an authorisation given by the patent holder to a generic company to produce a patented drug while a compulsory ...
Covid-19: Shortage of black fungus drug loomingOn May 22, there were 8,848 cases across India according to the central government. By May 26, the total number of cases went up to 11,717,...
Sun Pharma, US-based Rockwell Medical enter into licensing pact for Triferic in IndiaAs per the terms of the agreement, Sun Pharma will be the exclusive development and commercialisation partner for Triferic during the term ...
Time for India to be innovator nation in bio-pharmaceuticals: Expert"India has a strong potential to become a hub for bio-pharma innovation and play a leading role in collaborative research for the same."
Time for India to be innovator nation in bio-pharma: ExpertThis will have a huge economic impact creating high paying jobs, intellectual property and the real possibility for India to play a leading...
- US doublespeak on patent waiver bared
The country has resorted to its liberal use while objecting to concession on cancer drug by India.
- US doublespeak on patent waiver bared; resorts to its liberal use
Temporary importation of unapproved foreign drugs is considered in rare cases when there is a shortage of an approved drug that is critical...
- Indian drugmakers gear up to challenge frivolous MNC patents
Leading domestic drugmakers have decided to collectively challenge frivolous patent applications filed by multinationals in India under the...
- Stocks to Watch: Aditya Birla, Rel communications, HCL, Natco Pharma, Sun Pharmaceuticals
Markets are expected to be under pressure on Monday tracking sluggish cues from global markets.
- Sun Pharma gets USFDA approval to market generic Ethyol
Sun Pharmaceutical Industries has received approval from USFDA for abbreviated new drug application of amifostine for injection 500mg.